{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:40:23Z","timestamp":1762875623399,"version":"build-2065373602"},"reference-count":78,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.4158\/ep14068.ra","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T21:59:07Z","timestamp":1407880747000},"page":"945-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cushing Disease: Highlighting the Importance of Early Diagosis for Both de Novo and Recurrent Disease in Light of Evolving Treatment Patterns"],"prefix":"10.1016","volume":"20","author":[{"given":"Elizabeth M.","family":"Lamos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif M.","family":"Munir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP14068.RA_bb0005","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","article-title":"Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing\u2019s disease","volume":"16","author":"van der Pas","year":"2013","journal-title":"Pituitary"},{"key":"10.4158\/EP14068.RA_bb0010","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0015","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0020","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing\u2019s syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0025","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and longterm outcomes in treated Cushing\u2019s disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF03401535","article-title":"Pathogenesis of vascular complications in Cushing\u2019s syndrome","volume":"11","author":"Miljic","year":"2012","journal-title":"Hormones (Athens)."},{"key":"10.4158\/EP14068.RA_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04980.x","article-title":"Glucocorticoids. Mood, memory, and mechanisms","volume":"1179","author":"Wolkowitz","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"10.4158\/EP14068.RA_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.2002.tb04204.x","article-title":"Mechanisms of glucocorticoid action in bone","volume":"966","author":"Canalis","year":"2002","journal-title":"Ann N Y Acad Sci."},{"key":"10.4158\/EP14068.RA_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4158\/EP10368.OR","article-title":"Healthcare resource use and costs among patients with Cushing disease","volume":"17","author":"Swearingen","year":"2011","journal-title":"Endocr Pract."},{"key":"10.4158\/EP14068.RA_bb0050","doi-asserted-by":"crossref","first-page":"A162","DOI":"10.1016\/j.jval.2013.03.808","article-title":"Annual healthcare utlization and costs in Cushing\u2019s disease in the United States","volume":"16","author":"Broder","year":"2013","journal-title":"Value in Health."},{"key":"10.4158\/EP14068.RA_bb0055","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1210\/jc.2012-3663","article-title":"High long-term cortisol levels, measured in scalp hair, are associated with a history of cardiovascular disease","volume":"98","author":"Manenschijn","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0060","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0065","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing\u2019s syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11102-012-0398-4","article-title":"Venous thromboembolism in patients with Cushing\u2019s syndrome: need of a careful investigation of the prothrombotic risk profile","volume":"16","author":"Koutroumpi","year":"2013","journal-title":"Pituitary."},{"key":"10.4158\/EP14068.RA_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2265.2012.04479.x","article-title":"Hypercoagulable state in Cushing\u2019s syndrome is reversible following remission","volume":"78","author":"Kastelan","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11102-005-1051-2","article-title":"Cushing\u2019s syndrome and bone","volume":"7","author":"Mancini","year":"2004","journal-title":"Pituitary."},{"key":"10.4158\/EP14068.RA_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02067","article-title":"Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing\u2019s syndrome: a prospective, long-term study","volume":"154","author":"Kristo","year":"2006","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.endonu.2013.03.008","article-title":"Prognosis of patients treated for Cushing syndrome [in English, Spanish]","volume":"61","author":"Aulinas","year":"2014","journal-title":"Endocrinol Nutr."},{"key":"10.4158\/EP14068.RA_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12189","article-title":"Glucocorticoid-induced osteoporosis: lessons from Cushing\u2019s syndrome","volume":"79","author":"T\u00f3th","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2265.2003.01713.x","article-title":"Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing\u2019s disease: a prospective study","volume":"58","author":"Di Somma","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2265.1998.00486.x","article-title":"Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing\u2019s disease","volume":"48","author":"Di Somma","year":"1998","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0115","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2002-021494","article-title":"Nephrolithiasis in Cushing\u2019s disease: prevalence, etiopathogenesis, and modification after disease cure","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygcen.2010.07.004","article-title":"Cushing\u2019s syndrome, glucocorticoids and the kidney","volume":"169","author":"Smets","year":"2010","journal-title":"Gen Comp Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0125","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.tvjl.2011.05.027","article-title":"Hypercortisolism affects glomerular and tubular function in dogs","volume":"192","author":"Smets","year":"2012","journal-title":"Vet J."},{"key":"10.4158\/EP14068.RA_bb0130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1530\/eje.1.02040","article-title":"Glomerular filtration rate in patients with Cushing\u2019s disease: a matched case-control study","volume":"153","author":"Haentjens","year":"2005","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0135","first-page":"3083","article-title":"Menstrual abnormalities in women with Cushing\u2019s disease are correlated with hypercortisolemia rather than raised circulating androgen levels","volume":"83","author":"Lado-Abeal","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4158\/EP12247.OR","article-title":"Persistence of Cushing\u2019s disease symptoms and comorbidities after surgical cure: a long-term, integral evaluation","volume":"19","author":"Espinosa-de-los-Monteros","year":"2013","journal-title":"Endocr Pract."},{"key":"10.4158\/EP14068.RA_bb0145","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2004-2361","article-title":"Cushing\u2019s syndrome during pregnancy: personal experience and review of the literature","volume":"90","author":"Lindsay","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/09513590.2011.632789","article-title":"Cushing disease with pregnancy","volume":"28","author":"Gopal","year":"2012","journal-title":"Gynecol Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2012.05.030","article-title":"Adrenalectomy for adrenocortical adenoma causing Cushing\u2019s syndrome in pregnancy: a case report and review of literature","volume":"165","author":"Sammour","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.4158\/EP14068.RA_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.endonu.2013.03.008","article-title":"Prognosis of patients treated for Cushing syndrome [in English, Spanish]","volume":"61","author":"Aulinas","year":"2013","journal-title":"Endocrinol Nutr."},{"key":"10.4158\/EP14068.RA_bb0165","first-page":"1949","article-title":"Loss of brain volume in endogenous Cushing\u2019s syndrome and its reversibility after correction of hypercortisolism","volume":"87","author":"Bourdeau","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0170","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-13-0471","article-title":"Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with longterm remission of Cushing\u2019s disease: a case-control study","volume":"169","author":"Andela","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0175","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11102-013-0484-2","article-title":"Disease-specific quality of life evaluation and its determinants in Cushing\u2019s syndrome: what have we learnt?","volume":"17","author":"Badia","year":"2014","journal-title":"Pituitary."},{"key":"10.4158\/EP14068.RA_bb0185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0190","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month Phase 3 study of pasireotide in Cushing\u2019s disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14068.RA_bb0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","article-title":"The natural history of Cushing\u2019s syndrome","volume":"13","author":"Plotz","year":"1952","journal-title":"Am J Med."},{"key":"10.4158\/EP14068.RA_bb0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Int Med."},{"key":"10.4158\/EP14068.RA_bb0210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing\u2019s syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2011.12","article-title":"Management of Cushing disease","volume":"7","author":"Tritos","year":"2011","journal-title":"Nat Rev Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/EJE-13-0634","article-title":"Longterm remission and recurrence rates after first and second transsphenoidal surgery for Cushing\u2019s disease: care reality in the Munich Metropolitan Region","volume":"170","author":"Dimopoulou","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","article-title":"Late recurrences of Cushing\u2019s disease after initial successful transsphenoidal surgery","volume":"93","author":"Patil","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0235","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing\u2019s Disease during Active Disease and 1 Year after Disease Remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0240","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1227\/01.NEU.0000374722.50042.FF","article-title":"Utility of the immediate postoperative cortisol concentrations in patients with Cushing\u2019s disease","volume":"67","author":"Sughrue","year":"2010","journal-title":"Neurosurgery."},{"key":"10.4158\/EP14068.RA_bb0245","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing\u2019s disease: predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2265.2009.03723.x","article-title":"3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing\u2019s syndrome","volume":"72","author":"Erickson","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00006123-199702000-00001","article-title":"Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience","volume":"40","author":"Ciric","year":"1997","journal-title":"Neurosurgery."},{"key":"10.4158\/EP14068.RA_bb0260","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0265","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.wneu.2012.10.008","article-title":"Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series","volume":"80","author":"Cavallo","year":"2013","journal-title":"World Neurosurg."},{"key":"10.4158\/EP14068.RA_bb0270","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3171\/2014.1.JNS131228","article-title":"Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus","volume":"120","author":"Woodworth","year":"2014","journal-title":"J Neurosurg."},{"key":"10.4158\/EP14068.RA_bb0275","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.03082.x","article-title":"Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing\u2019s syndrome: a review of the Mayo Clinic experience","volume":"68","author":"Chow","year":"2008","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0280","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review: outcome of bilateral adrenalectomy in Cushing\u2019s syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0285","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease","volume":"336","author":"Estrada","year":"1997","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14068.RA_bb0290","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1990.tb03883.x","article-title":"Long-term follow-up of low-dose external pituitary irradiation for Cushing\u2019s disease","volume":"33","author":"Littley","year":"1990","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0295","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3171\/2013.7.JNS13217","article-title":"Results of gamma knife surgery for Cushing\u2019s disease","volume":"119","author":"Sheehan","year":"2013","journal-title":"J Neurosurg."},{"key":"10.4158\/EP14068.RA_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jc.2007-1220","article-title":"Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas","volume":"93","author":"Petit","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1530\/EJE-07-0514","article-title":"Ketoconazole revisited: a preoperative or postoperative treatment in Cushing\u2019s disease","volume":"158","author":"Castinetti","year":"2008","journal-title":"Eur J Endocrinol."},{"author":"U.S. Food and Drug Administration","key":"10.4158\/EP14068.RA_bb0310"},{"author":"European Medicines Authority","key":"10.4158\/EP14068.RA_bb0315"},{"key":"10.4158\/EP14068.RA_bb0320","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","article-title":"Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing\u2019s syndrome","volume":"35","author":"Verhelst","year":"1991","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0325","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing\u2019s disease in 76 patients from a single center","volume":"167","author":"Baudry","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0335","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2013-2117","article-title":"LCI699, a potent 11\u03b2-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing\u2019s disease: results from a multicenter, proof-of-concept study","volume":"99","author":"Bertagna","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"author":"Pivonello","key":"10.4158\/EP14068.RA_bb0340"},{"key":"10.4158\/EP14068.RA_bb0345","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing\u2019s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0350","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing\u2019s disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP14068.RA_bb0360","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4158\/EP12149.RA","article-title":"A new therapeutic approach in the medical treatment of Cushing\u2019s syndrome: glucocorticoid receptor blockade with mifepristone","volume":"19","author":"Fleseriu","year":"2013","journal-title":"Endocr Pract."},{"key":"10.4158\/EP14068.RA_bb0365","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0375","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-013-0475-3","article-title":"Combination therapy for Cushing\u2019s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?","volume":"17","author":"Barbot","year":"2014","journal-title":"Pituitary."},{"key":"10.4158\/EP14068.RA_bb0380","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing\u2019s syndrome","volume":"96","author":"Kamenick\u00fd","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14068.RA_bb0385","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing\u2019s disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N Engl J Med."},{"issue":"suppl 1","key":"10.4158\/EP14068.RA_bb0390","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000314315","article-title":"Hypertension in Cushing\u2019s syndrome: from pathogenesis to treatment","volume":"92","author":"Cicala","year":"2010","journal-title":"Neuroendocrinology."},{"key":"10.4158\/EP14068.RA_bb0395","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2265.2001.01026.x","article-title":"Longterm mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia","volume":"54","author":"Newfield","year":"2001","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP14068.RA_bb0400","doi-asserted-by":"crossref","first-page":"E1938","DOI":"10.1210\/jc.2012-2432","article-title":"Glucocorticoid replacement and mortality in patients with non-functioning pituitary adenoma","volume":"97","author":"Zueger","year":"2012","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/D18WG40320262586.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:31Z","timestamp":1761515851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20422347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":78,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1530891X20422347"],"URL":"https:\/\/doi.org\/10.4158\/ep14068.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cushing Disease: Highlighting the Importance of Early Diagosis for Both de Novo and Recurrent Disease in Light of Evolving Treatment Patterns","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14068.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}